WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Biosciences Inc Stock Ownership - Who owns Coherus Biosciences?

Insider buying vs selling

Have Coherus Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mats WahlstromDirector2024-02-0144,991$1.67
$75.00kBuy
Mats WahlstromDirector2024-02-0114,997$1.67
$25.00kBuy
Bryan J. McMichaelOfficer2024-01-201,707$2.44
$4.17kSell
Dennis M. LanfearPresident CEO2024-01-2011,218$2.44
$27.37kSell
Paul ReiderChief Commercial Officer2024-01-204,854$2.44
$11.84kSell
Bryan J. McMichaelOfficer2024-01-071,707$2.87
$4.90kSell
Dennis M. LanfearPresident CEO2024-01-0411,781$2.92
$34.40kSell
Paul ReiderChief Commercial Officer2024-01-042,275$2.92
$6.64kSell
Mcdavid StilwellChief Financial Officer2023-12-3118,440$3.33
$61.41kSell
Paul ReiderChief Commercial Officer2023-12-132,049$2.37
$4.86kSell

1 of 2

CHRS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.79%11,230,522$18.75MInstitution
Rubric Capital Management LP9.07%10,400,000$17.37MInstitution
Vanguard Group Inc8.79%10,079,554$16.83MInstitution
Temasek Holdings Private Ltd6.43%7,381,116$12.33MInstitution
Vsciences Investments Pte Ltd6.43%7,381,116$12.33MInsider
Lilly Co Eli2.65%3,042,019$5.08MInsider
Kohlberg Kravis Roberts Co LP2.65%3,036,076$5.07MInstitution
Daiichi Sankyo Company Ltd2.50%2,867,426$4.79MInsider
Citadel Advisors LLC2.39%2,742,627$4.58MInstitution
Morgan Stanley2.32%2,664,169$4.45MInstitution

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS71.17%18.37%Net Buying
TSVT63.69%36.31%Net BuyingNet Buying
DSGN42.21%57.79%Net BuyingNet Buying
AKBA27.21%8.92%Net SellingNet Selling
TRVI21.99%78.01%Net BuyingNet Buying

Coherus Biosciences Stock Ownership FAQ

Who owns Coherus Biosciences?

Coherus Biosciences (NASDAQ: CHRS) is owned by 71.17% institutional shareholders, 18.37% Coherus Biosciences insiders, and 10.47% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Biosciences shareholder, owning 7.38M shares representing 6.43% of the company. Vsciences Investments Pte Ltd's Coherus Biosciences shares are currently valued at $12.33M.

If you're new to stock investing, here's how to buy Coherus Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.